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ABSTRACT 
ARHI (DIRAS3) is an imprinted tumor suppressor gene whose expression is lost in the majority 
of breast and ovarian cancers.  Unlike its homologs Ras and Rap, ARHI functions as a tumor 
suppressor.  Our previous study showed that ARHI can interact with transcription activator 
Stat3 and inhibit its nuclear translocation in human breast and ovarian cancer cells.  To identify 
proteins that interact with ARHI in nuclear translocation, we have performed proteomic analysis 
and identified several importins that can associate with ARHI.  To further explore this novel 
finding, we have purified 10 GST-importin fusion proteins (importin 7, 8, 13, β1, α1, α3, α5, α6, 
α7 as well as mutant α1).  Using a GST-pull down assay, we found that ARHI can bind strongly 
to most importins; however, its binding is significantly reduced with an importin α1 mutant 
which contains an altered nuclear localization signal (NLS) domain.  In addition, an ARHI 
N-terminal deletion mutant (NTD) exhibits much less binding to all importins than does wild 
type ARHI  ARHI and NTD proteins were purified and tested for their ability to inhibit nuclear 
importation of proteins in HeLa cells.  ARHI protein inhibits interaction of Ran-importin 
complexes with GFP fusion proteins that contain an NLS domain and a beta-like import receptor 
binding domain, blocking their nuclear localization.  Addition of ARHI also blocked nuclear 
localization of phosphorylated Stat3β.  By GST-pull down assays, we found that ARHI could 
compete for Ran-impotins binding. Thus, ARHI-induced disruption of importin binding to cargo 
proteins including Stat3 could serve as an important regulatory mechanism that contributes to the 
tumor suppressor function of ARHI. 
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INTRODUCTION 
Transport of macromolecules between the nucleus and cytoplasm is critical for the 
normal function of eukaryotic cells.  Two groups of karyopherins - importins and exportins - 
mediate RanGTPase-dependent transport through the nuclear pore (1).  During malignant 
transformation, aberrant nucleocytoplasmic transport of transcription factors (such as Stat3 and 
E2F1) (2, 3) and their regulatory kinases (such as Sgk and Erk/MAPK) (4) occurs through 
impaired nuclear import, enhanced export, suppression of degradation, and sequestration in 
protein aggregates.  Conversely, secreted factors such as CCN proteins, EGF, FGFs and their 
receptors are often detected in the nucleus of cancer cells.  Nuclear localization of these 
molecules has been correlated with tumor progression and poor prognosis for patient survival (5, 
6). 
The classical nuclear import pathway consists of importin α and β. Whereas importin α  
interacts with a nuclear localization signal (NLS) in the cargo, importin β binds to the 
autoinhibitory domain on importin α and mediates the transport of the trimeric complex from the 
cytoplasm to the nucleus through the nuclear pores.  Once inside the nucleus, the small GTP 
binding protein Ran (RanGTP) dissociates the complex by interacting with importin β.  
importin α and β are shuttled separately back to the cytoplasm (7).  There are more than 20 
members in the importin family, including importin α1, α3, α4, α5, α6, α7, importin β1, 7, 8, 9, 
and 13 (8, 9, 10, 11, 12). Importin αs are composed of a flexible N-terminal importin-β-binding 
(IBB) domain. The flexible IBB domain interacts either in trans with importin β or in cis with the 
cNLS-binding groove (8). Importin βs have in common an N-terminal Ran binding domain. 
Importins direct the import of various cargoes and may have different functions. For example, 
importin β/importin 7 heterodimer is a functional nuclear import receptor for histone H1 (10); 
 5
importin β, transportin, importin 7, and importin 9 promoted efficient import of c-Jun into the 
nucleus; importin alpha, by contrast, inhibited nuclear import of c-Jun in vitro (11). Importin 13, 
a recently identified importin β family member, regulates nuclear import of the glucocorticoid 
receptor in airway epithelial cells (12).  
Ran is a small Ras-like GTP-binding protein that switches between a GTP- and a 
GDP-bound form by GTP hydrolysis and nucleotide exchange (13). The GTPase Ran plays a 
crucial role in nucleo-cytoplasmic transport of tumor suppressors, proto-oncogenes, signaling 
molecules and transcription factors. The RanGTPase cycle provides directionality to 
nucleocytoplasmic transport, regulating interactions between cargoes and nuclear transport 
receptors of the importin-β family. The common principle underlying these diverse functions 
throughout the cell cycle is thought to be anisotropy of the distribution of RanGTP (the RanGTP 
gradient), driven by the chromatin-associated guanine nucleotide exchange factor RCC1 (14).  
ARHI is a maternally imprinted tumor suppressor gene that encodes a 26 kD protein with 
55-62% homology to Ras and Rap (15).  In contrast to Ras, ARHI contains a 34 amino acid 
N-terminal extension and inhibits growth, motility and invasion of cancer cells (15, 16).  Our 
previous study showed that ARHI can interact with transcription activator Stat3 and inhibit its 
nuclear translocation and transcription activity in human breast and ovarian cancer cells (17).  
Deletion of the N-terminus of ARHI (NTD) significantly compromised its inhibitory activity, 
suggesting that this unique extension contributes to ARHI’s inhibitory effects on Stat3-mediated 
transcriptional activities (17).  To identify additional ARHI-interacting proteins, we have 
performed proteomic analysis and found that ARHI is complexed with several importin proteins.  
We have explored the possibility that ARHI might displace cargo proteins, including Stat3, and 
inhibit their nuclear localization.   
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RESULTS 
ARHI interacts with importins.  Our previous studies have shown that, when ARHI and Stat3 
were both expressed in SKOv3 cells, ARHI formed a complex with Stat3 in the cytoplasm and 
prevented interleukin-6–induced Stat3 accumulation in the nucleus (17).  To identify the 
protein(s) interacting with ARHI in the nuclear import process, we performed proteomic analysis.  
Wild-type ARHI and its NTD mutant were expressed in SKBr3 breast cancer cells with a dual 
adenovirus system (18).  Cells infected with the LacZ adenovirus served as a control.  ARHI- 
or NTD-protein complexes were immunoprecipitated using a specific ARHI antibody and 
co-immunoprecipitated proteins were analyzed by mass spectrometry.  Several novel interacting 
proteins were identified in complexes with wild type ARHI that bound less intensely to the NTD 
ARHI mutant.  Three of these proteins (Fig. 1A) belong to the family of importins (importin 7, 
importin 9, importin α re-exporter).  These results were further confirmed by 
co-immunoprecipitation assays.  As shown in Figure 1B and 1C, in SKBr3 and HeLa cells, 
ARHI antibody could immunoprecipitate importin 7, 9 and β1, and improtin 7 antibody could 
also immunoprecipitate ARHI (Fig. 1D).  NTD:importin binding was much reduced compared 
to wild-type ARHI:importin interaction. 
 
ARHI can bind to multiple importins through the NLS domain.  To investigate the 
ARHI:importin interaction, 10 GST- importins fusion proteins (importin α1, α1 mutant, α3, α5, 
α6, α7, importin β1, and importin 7, 8, and 13) were purified.  GST protein was used as a 
negative control.  ARHI bound strongly to most of importins in GST pull-down assays.  
Binding of ARHI to importin α1 was stronger than binding of ARHI to an importin α1 mutant 
that contained an altered nuclear localization signal (NLS) domain (Fig. 2A).  
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N-terminal of ARHI may mediate the binding with importins.  Our previous studies 
demonstrated that deletion of the unique 34 amino acid N-terminal extension of ARHI nearly 
abolished its inhibitory effect on cancer cell growth (16) and its ability to block the DNA binding 
activity of Stat3 (17).  Thus, the ARHI N-terminal extension could be important for its 
biological function.  In the proteomic analysis and immunoprecipitation assays (Fig. 1), NTD 
protein exhibited much less binding to importins.  To test further the possible role of the 
N-terminus of ARHI in binding importins, equal amounts of ARHI complexes and NTD 
complexes were tested in GST-pull down assays.  As presented in Figure 2B, wild type ARHI 
bound more strongly to most importins than did the truncated NTD mutant, consistent with the 
possibility that the 34 amino acid N-terminal extension of ARHI mediates ARHI-importin 
binding.  
 
ARHI can block protein nuclear localization signal.  Recent studies have shown that 
interaction of importins with the Ran protein is required to facilitate transport of cargo proteins 
into the nucleus (13).  Since ARHI and Ran belong to the same family of small G-proteins, 
ARHI therfore may antagonize importins’ interaction with Ran.  To test this hypothesis, we 
have purified ARHI and NTD proteins and assessed their effects on nuclear transport of cargo 
proteins in HeLa cells.  In nuclear import assays, an NLS-GFP fusion protein could be imported 
into the nucleus in association with importin α7, importin β1 and RanGDP (Fig. 3), whereas the 
BIB (beta-like import receptor binding)-GFP fusion protein only needed help from importin 7 
and RanGDP for nuclear localization (Fig. 4).  ARHI protein blocked the interaction of NLS 
with Ran-importin β and α complexes, and also the interaction of BIB with Ran-importin 7 
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complexes, preventing their nuclear translocation (Figs. 3, 4).  In comparison, ARHI-NTD 
protein did not block these interactions or nuclear transport (Figs. 3, 4). 
 
ARHI can block Stat3 protein nuclear localization signal.  Using a similar GST pull-down 
assay, Stat3 protein was shown to bind importins β1, α1, α3, α6, and α7, but not the other 
importins (Fig. 5A).  After IL-6 stimulation, the level of pStat3 greatly increased. Importins 
bound both to phosphorylated Stat3 (after IL-6 stimulation) and non-phospharylated Stat3 (no 
IL-6 stimulation), but importin binding to pStat3 was much stronger.  To investigate if ARHI 
could block Stat3 protein nuclear translocation, we have produced a phosphorylated Stat3β 
protein (residues 127-722), which contained the binding site to importins.  This protein was 
labeled with FITC and evaluated in the nuclear import assay.  As shown in Figure 5B, pStat3β 
protein alone was concentrated at nuclear pores; when importins and Ran were added to the 
system, pSTAT3β was distributed in the nucleus. Addition of purified ARHI protein blocked 
Ran-dependent pSTAT3β nuclear translocation. 
 
ARHI can compete for importin-Ran binding. ARHI (DIRAS3) and Ran share a 22% 
sequence identity and are expected to have a similar overall structure. Although the crystal 
structure of ARHI is not available, those of the closest neighbors in the Ras family, DIRAS1 and 
DIRAS2, are. We obtained a homology model for ARHI via the SWISS-MODEL server 
(http://swissmodel.expasy.org/). The model was generated using the DIRAS2 structure (PDB 
code: 2ERX) as the template and it covers residues 37 to 206 of the protein’s 229 residues. As 
shown in Figure 6A, when the ARHI model is superimposed onto the crystal structure of Ran 
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(PDB code: 1IRB, chain A) (26), the structural conservancy is clear. A DaliLite 
(http://www.ebi.ac.uk/DaliLite/) pairwise comparison resulted in a Z-score of 23.4 and Cα 
RMSD of 2.4 Å, over 165 aligned residues. In the crystal structure of the importin β:Ran 
complex (26), Ran utilizes an extensive surface in binding to importin β (Fig. 6B). To determine 
whether ARHI binds to the same region of importin β as Ran and could compete for 
importin-Ran binding, we have performed GST-pull down assays and found Ran strongly bound 
to both importin β1 and 13, ARHI protein could reduce at least 50% of these binding ability (Fig. 
6C), but NTD protein could not.   
 
DISCUSSION 
Stat3, a latent transcription factor, transduces signals from the cell surface to the nucleus and 
activates gene transcription, triggering proliferation, resistance to apoptosis, motility, invasion 
and angiogenesis (21, 22).  Recent studies clearly demonstrate that Stat3 is required for both 
tumor initiation and promotion (21).  Stat3 is frequently phosphorylated, activated in the 
majority of breast and ovarian cancers (23), where cytokines and growth factors such as IL-6 
bind to specific receptors and activate JAK2 which, in turn, phosphorylates Stat3 and prompts 
translocation of pStat3 to the nucleus.  The classic NLS-importin pathway has been reported to 
mediate the nuclear translocation of Stat3.  Liu L et al. reported that the Stat3 nuclear import is 
mediated by importin-α3 (24), whereas other studies have shown that the regulation of Stat3 
nuclear import is through importins α5 and α7 (25).  Few studies have considered factors which 
regulate translocation of pStat3.  
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From our previous studies, re-expression of the putative tumor suppressor gene ARHI in cancer 
cells markedly inhibited binding of pStat3 to Stat response elements in target gene promoters and 
downregulated Stat3-dependent promoter activity without significantly affecting Stat3 
phosphorylation (17).  When ARHI and Stat3 were co-expressed in SKOv3 ovarian cancer cells, 
ARHI formed a complex in the cytoplasm with Stat3 and prevented IL-6-induced Stat3 
translocation to the nucleus (17).  Our present study has elucidated the mechanism by which 
ARHI prevents nuclear translocation of pStat3.  Nuclear import assays have shown that pStat3 
can be translocated to the nucleus in the presence of Ran and importins (Fig 5B), whereas 
non-phosphorylated Stat3 could not (data not shown).  ARHI protein bound to importins (Figs. 
1-2) and blocked nuclear translocation of pStat3 (Fig. 5B).  ARHI also blocked nuclear 
translocation of NLS-GFP and BIB-GFP in the presence of Ran and appropriate importins.  
Thus, ARHI might affect nuclear localization of Stat3, but might also affect transport of other 
proteins that are required for oncogenesis.  
 
The precise mechanism by which ARHI disrupts the interaction of pStat3, Ran and importins 
remains to be elucidated.  ARHI is a member of Ras superfamily, but contains a unique 34 
residue extension at the N-terminus.  Like Ras, ARHI can bind to GTP with high affinity, but 
has low intrinsic GTPase activity (16).  ARHI associates with the cell membrane after 
prenylation at the C-terminal cysteine residue.  Mutation of the conserved CAAX box at the 
C-terminus led to a loss of its membrane association ability and a modest decrease in its ability 
to inhibit cell growth (16).  Most strikingly, deletion of ARHI’s unique N-terminal extension 
nearly abolishes its inhibitory effect on cell growth (16, 17).  In the present study, the NTD 
mutant lost much of the ability to bind importins and did not block the nuclear translocation of 
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NLS-GFP or BIB-GFP.  This suggests that interaction of the N-terminal extension of ARHI to 
importin may be required to prevent effective interaction of Ran-importin complexes with NLS 
and BIB.  Interestingly, C-terminal deletion mutants of ARHI localize in the nucleus (data not 
shown), raising the possibility that accumulation of pStat3 in the cytoplasm in the presence of 
wild type ARHI protein could result from direct binding of ARHI to Stat3, which we have 
demonstrated (17), or to lack of an effective nuclear transport mechanism. As wild type ARHI 
exhibits a nuclear localization signal on its N-terminal extension, the ARHI might compete with 
cargo for binding to importins in the presence of Ran.  Once bound, ARHI could trap importins 
in the cytoplasm as the small G protein is tethered to cell membranes through its prenylated 
C-terminus.  Our present study showed that the structural conservancy between ARHI and Ran 
is clear (Fig. 6A), ARHI protein could compete for at least 50% of importin-Ran binding ability 
(Fig. 6C), suggesting that ARHI binds to the same region of importin β as Ran does and 
ARHI-induced disruption of Ran-importin binding could serve as an important regulatory 
mechanism that contributes to the tumor suppressor function of ARHI. 
 
MATERIALS AND METHODS 
Cell lines and reagents.  SKBr3 human breast cancer cell line was maintained as described (16).  
HeLa cells were grown at 37°C to near confluence in Dulbecco’s Modified Eagle’s Medium 
containing 10% fetal calf serum.  Constructs of Ran and importin α1 mutant, as well as anti- 
importin β1 antibody were provided by Dr. Karsten Weis (University of California Berkeley).  
Constructs of GST, GST-importin 7, GST-importin 8, GST-GFP, GST-GFP-BIB, GST-GFP-NLS 
were provided by Dr. Keith Yamamoto (University of California San Francisco).  Anti-importin 
7 and anti-importin 9 antibodies were obtained from Dr. Dirk Görlich (University of Heidelberg, 
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Germany).  Anti-Ran and anti-GST antibodies were purchased from Upstate Biotechnology Inc. 
(Billerica, MA). Anti-ARHI antibody was produced by our group as previously described (16).  
Adenovirus constructs expressing LacZ, ARHI and NTD were prepared (18).  The reagents for 
a nuclear import assay (digitonin, ATP, GTP, creatine phosphate, creatine kinase) were purchased 
from Sigma (St. Louis, MO).  
 
Proteomics analysis. Wild-type ARHI and its NTD mutant were re-expressed in the breast 
cancer cell line SKBr3 with a dual adenovirus system (18).  LacZ adenovirus-infected cells 
were used as a control.  ARHI interacting proteins were immunoprecipitated using an ARHI 
monoclonal antibody and further purified using Protein G beads (Pierce, Rockfold, IL).  
Proteins were separated on a 15% SDS-PAGE gel and analyzed by mass spectrometry at the 
University of Texas M.D. Anderson Cancer Center Proteomics Facility. 
 
Western blot analysis.  Confluent SKBr3 cells were lysed and the cell lysates were clarified by 
centrifugation for 5 min at 14,000 rpm at room temperature.  Equal amounts of total cellular 
proteins were electrophoresed in 15 % SDS/PAGE and transferred to polyvinylidene fluoride 
membrane (Millipore, Billerica, MA).  The membrane was immunoblotted with antibodies and 
signals developed by using an ECL system (Amersham, Piscataway, NJ). 
 
Fusion protein expression and purification.  GST, GST-importin α1, α3, α5, α6, α7, 
GST-importin α1 mutant, GST-importin β1, 7, 8, and 13 were all expressed in BL21 (DE3) 
Escherichia coli (Stratagene).  Overnight bacterial cultures in LB/Ampicillin were diluted 1/100 
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and grown to an OD595 of 0.6 to 0.8 at 37°C.  Cultures were cooled, induced with 0.25 mM 
IPTG overnight at 16°C and harvested by centrifugation.  Cell pellets were re-suspended in 
lysis buffer (50 mM Tris, pH 8.0, 150 mM NaCl, 1 mM EDTA, 1 mM DTT, 1 µg/ml leupeptin, 1 
µg/ml  pepstatin, 1 µg/ml aprotinin, and 1 mM PMSF), sonicated, and clarified at 40,000 x g for 
30 min at 4°C.  After centrifugation, the supernatant fraction was further purified on an AKTA 
FPLC system using a glutathione sepharose column and a Superdex 200 gel filtration column.  
Tyrosine phosphorylated Stat3β (residues 127-722) (pStat3β) was purified as published (19), 
briefly, the core fragment of STAT3β was co-expressed with the Elk kinase in E. coli. The 
identity of the phosphoprotein was confirmed by using mass spectrometry.  
The ARHI and NTD cDNA sequences were PCR amplified from pcDNA3-ARHI plasmid 
DNA and cloned into the pQE30 vector.  The importin 7 coding sequence was retrieved from 
the GST-importin 7 plasmid by restriction digestion and inserted into the pQE30 vector.  For the 
nuclear import substrates, GST-GFP-BIB and GST-GFP-NLS proteins were purified by 
glutathione sepharose beads (Amersham) according the manufacturer's instructions.  pQE-Ran, 
pQE-importin 7, pQE-ARHI, and pQE-NTD were expressed in SG13009 competent cells and 
purified according to Nachury and Weis (20).  Importin β1 was cleaved from GST-β1 fusion by 
PreScission protease (GE Healthcare, Piscataway, NJ) and importin α7 was cleaved from 
GST-α7 fusion using TEV protease (Invitrogen, Carlsbad, CA), and the mixture was loaded on a 
HiTrap Q cartridge (Amerhsam) to separate GST from the importin proteins.  All fusion 
proteins were concentrated using Centricon 30 concentrators, aliquoted, flash frozen in liquid 
nitrogen, and stored at -80 oC. 
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Labelling of pStat3β.  pStat3β proteins were FITC-labeled using a FITC Protein Labeling kit 
(Pierce) according manufacturer’s instructions. 
 
GST pull-down assay.  GST-importin fusion proteins (2-4 μg) were mixed with 10-30 μg of 
cell lysates from SKBr3 cells in binding buffer (20 mM Hepes, pH 7.9, 150 mM NaCl, 0.5 mM 
EDTA, 10 % Glycerol, 0.1% Triton X-100, 1 mM DTT).  The mixture was incubated with 
shaking at 4°C for 1 h.  Fifteen microliters of glutathione-sepharose beads, pre-equilibrated in 
TEE buffer (50 mM Tris, pH 7.9, 1 mM EDTA, 1 mM EGTA) were added to the mixture and 
incubated with shaking at 4°C for another 1 h.  The beads were collected and washed 4-5 times 
with Washing buffer (20 mM Hepes, pH 7.5, 100 mM KCl, 2.5 mM MgCl2, 1% glycerol, 1% 
Triton X-100) and once with ice-cold PBS.  The beads were resuspended in 20 μl of 2X SDS 
loading buffer and then boiled for 5 min.  The soluble proteins were separated on 15% 
SDS-PAGE gels for Coomassie blue staining or western-blotting analysis. 
 
Nuclear import assay. HeLa cells were grown on glass cover slips for 40-42 h.  Cells were 
then washed twice with ice-cold Transport buffer (20 mM HEPES, pH 7.3, 110 mM KOAc, 5 
mM NaOAc, 2 mM MgOAc, 2 mM DTT, 1 mM EGTA), incubated with 40 μg/ml digitonin in 
Transport buffer for 6 min on ice, washed twice in cold Transport buffer, and kept on ice for 20 
min.  Cover slips containing permeabilized cells were incubated for 30 min at 30°C with a 30 μl 
nuclear import reaction mixture [2 μM GFP-tagged import substrate or 4 μM FITC labeled 
p-Stat3β and an ATP-regenerating system (1 mM ATP, 5 mM creatine phosphate, 10 U/ml 
creatine kinase, 0.5 mM GTP)].  Some experiments were complemented with 3 μM RanGDP, 3 
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μM importin α7, 2 μM importin β1, 3 μM ARHI or 3 μM ARHI-NTD.  After the import 
reactions were completed, the cells were rinsed once in PBS, fixed in 4% paraformaldehyde in 
PBS, and analyzed by fluorescence microscopy. 
    
ACKNOWLEDGEMENTS 
This work has been supported by grants from the National Caner Institute, CA 80957 (Y.Yu) and 
CA 64602 (R.C.Bast), and from the National Foundation for Cancer Research LF 2004- 
00009224HM (R.C.Bast). 
 16
REFERENCES   
1. Terry LJ, Shows EB, Wente SR. (2007). Crossing the nuclear envelope: hierarchical 
regulation of nucleocytoplasmic transport. Science 318: 1412-1416.  
2. Herrmann A, Vogt M, Mönnigmann M, Clahsen T, Sommer U, Haan S, et al. (2007). 
Nucleocytoplasmic shuttling of persistently activated STAT3. J Cell Sci 120: 3249-3261.  
3. Ivanova IA, Vespa A, Dagnino L. (2007). A novel mechanism of E2F1 regulation via 
nucleocytoplasmic shuttling: determinants of nuclear import and export. Cell Cycle 6: 
2186-2195.  
4. Buse P, Maiyar AC, Failor KL, Tran S, Leong ML, Firestone GL. (2007). The 
stimulus-dependent co-localization of serum- and glucocorticoid-regulated protein 
kinase (Sgk) and Erk/MAPK in mammary tumor cells involves the mutual interaction 
with the importin-alpha nuclear import protein. Exp Cell Res 313: 3261-3275.   
5. Planque N. (2006). Nuclear trafficking of secreted factors and cell-surface receptors: 
new pathways to regulate cell proliferation and differentiation, and involvement in 
cancers. Cell Commun Signal 4:7.  
6. Lo HW, Ali-Seyed M, Wu Y, Bartholomeusz G, Hsu SC, Hung MC. (2006). 
Nuclear-cytoplasmic transport of EGFR involves receptor endocytosis, importin beta1 
and CRM1. J Cell Biochem 98: 1570-1583.  
7. Otis KO, Thompson KR, Martin KC. (2006). Importin-mediated nuclear transport in 
neurons. Curr Opin Neurobiol 16:329-335.  
8. Goldfarb DS, Corbett AH, Mason DA, Harreman MT, Adam SA. (2004). Importin alpha: 
a multipurpose nuclear-transport receptor. Trends Cell Biol 14: 505-514. 
 17
9. Harel A, Forbes DJ. (2004). Importin beta: conducting a much larger cellular symphony. 
Mol Cell 16:319-330.  
10. Jäkel S, Albig W, Kutay U, Bischoff FR, Schwamborn K, Doenecke D et al. (1999). The 
importin beta/importin 7 heterodimer is a functional nuclear import receptor for histone 
H1. EMBO J 18: 2411-2423. 
11. Waldmann I, Wälde S, Kehlenbach RH. (2007). Nuclear import of c-Jun is mediated by 
multiple transport receptors. J Biol Chem 282:27685-27692.  
12. Tao T, Lan J, Lukacs GL, Haché RJ, Kaplan F. (2006). Importin 13 regulates nuclear 
import of the glucocorticoid receptor in airway epithelial cells. Am J Respir Cell Mol 
Biol 35: 668-680.  
13. Moore MS, and Blobel G. (1993). The GTP-binding protein Ran/TC4 is required for 
protein import into the nucleus. Nature 365:661-663.  
14. Kaláb P, Pralle A, Isacoff EY, Heald R, Weis K. (2006). Analysis of a RanGTP-regulated 
gradient in mitotic somatic cells. Nature 440: 697-701. 
15. Yu YH, Xu FJ, Peng HQ, Fang XJ, Zhao SL, Li Y et al. (1999). NOEY2 (ARHI), an 
imprinted putative tumor suppressor gene in ovarian and breast carcinomas. Proc Natl 
Acad Sci USA 96:214-219.  
16. Luo RZ, Fang X, Marquez R, Liu S-Y, Mills GB, Liao W S-L et al. (2003). ARHI is a 
Ras-related small G-protein with a novel N-terminal extension that inhibits growth of 
ovarian and breast cancers. Oncogene 22: 2897-2909. 
17. Nishimoto A, Yu Y, Lu Z, Liao WS-L, Chen X, Mills GB et al. (2005). ARHI Directly 
Inhibits STAT3 Translocation and Activity in Human Breast and Ovarian Cancer Cells.  
 18
Cancer Res 65: 6701-6710. 
18. Bao JJ, Le XF, Wang RY, Yuan J, Wang L, Atkinson EN et al. (2002). Reexpression of 
the tumor suppressor gene ARHI induces apoptosis in ovarian and breast cancer cells 
through a caspase-independent calpain-dependent pathway. Cancer Res 62: 7264-7272.  
19. Becker S, Corthals GL, Aebersold R, Groner B, Müller CW. (1998). Expression of a 
tyrosine phosphorylated, DNA binding Stat3beta dimer in bacteria. FEBS Lett 441: 
141-147. 
20. Nachury MV, Weis K. (1999). The direction of transport through the nuclear pore can be 
inverted. Proc Natl Acad Sci U S A 96: 9622-9627. 
21. Haura EB, Turkson J, Jove R. (2005). Mechanisms of disease: Insights into the emerging 
role of signal transducers and activators of transcription in cancer. Nat Clin Pract Oncol 
2: 315-324.  
22. Xie TX, Wei D, Liu M, Gao AC, Ali-Osman F, Sawaya R. et al. (2004). Stat3 activation 
regulates the expression of matrix metalloproteinase-2 and tumor invasion and 
metastasis. Oncogene 23: 3550-3560. 
23. Alvarez JV, Febbo PG, Ramaswamy S, Loda M, Richardson A, Frank DA. (2005). 
Identification of a genetic signature of activated signal transducer and activator of 
transcription 3 in human tumors. Cancer Res 65: 5054-5462. 
24. Liu L, McBride KM, Reich NC. (2005). STAT3 nuclear import is independent of 
tyrosine phosphorylation and mediated by importin-alpha3. Proc Natl Acad Sci U S A 
102: 8150-8155.  
25. Ma J, Cao X. (2006). Regulation of Stat3 nuclear import by importin alpha5 and 
 19
importin alpha7 via two different functional sequence elements. Cell Signal 18: 
1117-1126.  
26. Vetter IR, Arndt A, Kutay U, Görlich D, Wittinghofer A. (1999). Structural view of the 
Ran-Importin beta interaction at 2.3 A resolution. Cell 97: 635-646. 
 
 20
TITLES AND LEGENDS TO FIGURES: 
Figure 1. ARHI-importin form complexes. (A) Proteomic analysis. Wild-type ARHI and its NTD 
mutant were expressed in the SKBr3 breast cancer cells using a dual adenovirus system.  LacZ 
adenovirus infected cells served as the control.  A: ARHI complexes; B: NTD complexes; C: 
LacZ control.  Arrows point to protein bands corresponding to the indicated novel binding 
proteins. (B-D) Immunoprecipitation of ARHI-importin complexes. Protein lysates from (B) 
SKBr3 or (C) HeLa cells infected with ARHI, NTD, or LacZ adenoviruses were incubated with 
anti-ARHI antibody.  The immunoprecipitates were analyzed by Western blotting with 
anti-importin (Imp) 7, 9, β1 antibodies.  Mouse IgG was used as control.  (D) Proteins 
immunoprecipitated with anti-importin 7 antibodies were analyzed by Western analysis with 
anti-ARHI antibody. 
 
Figure 2.  ARHI-importin binding analyzed by GST pull-down assays.  (A) SKBr3 cells were 
infected with ARHI adenovirus and lysed.  Ten GST-importin (Imp) fusion proteins and ARHI 
antibody were used to detect ARHI-importin binding.  GST protein served as a control.  
Loading was measured with anti-GST antibody.  (B) Wild type ARHI binds more strongly to 
most importins than does the NTD mutant.  Equal amounts of ARHI or NTD protein lysates 
(induced by adenovirus in SKBr3 cells) were used in GST-pull down assays.  Nine GST fusion 
proteins and ARHI antibody were used to detect the binding.  GST protein did not bind to both 
ARHI and NTD. 
 
Figure 3.  Nuclear import assay for NLS-GFP.  NLS-GFP protein was mixed with RanGDP, 
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importin (Imp) α7, importin β1, and incubated with permeabilized HeLa cells.  Import assays 
were also performed with ARHI and NTD proteins. 
 
Figure 4.  Nuclear import assay for BIB-GFP.  BIB NLS-GFP protein was mixed with 
RanGDP, importin (Imp) α7 and incubated with permeabilized HeLa cells.  Import assays were 
also performed with ARHI and NTD proteins. 
 
Figure 5. ARHI can block pStat3β nuclear translocation. (A) Stat3-importin binding analyzed by 
GST-pull down assays.  SKBr3 cells were treated with or without IL-6 (10 ng/mL) for 30 
minutes before cells were harvested for cell lysate preparation.  Ten GST-importin (Imp) fusion 
proteins and Stat3/pStat3 antibodies were used to detect binding between Stat3 and importins.  
GST protein was used as a control.  (B) Nuclear import assay for pStat3β-GFP.  Purified 
pStat3β and RanGDP, importin α7, and importin β1 were incubated with permeabilized HeLa 
cells.  Import assays were also performed with ARHI protein. 
 
Figure 6. (A) Superimposition of the ARHI structural model (homology modeling, in red) and 
the Ran crystal structure (PDB code: 1IBR, chain A, in green). (B) A semi-transparent surface 
diagram of Ran (in the same orientation as in A), showing the side-chains of the residues (in red) 
involved in binding to importin β (26). Both diagrams were made using PyMOL 
(http://pymol.sourceforge.net/). (C) ARHI competes for importin-Ran binding. GST or 
GST-RanQ69L fusion proteins were bound to glutathione-Sepharose 4B, then incubated with 
Importin 13 (Imp 13)-His/Importin β1 (Impβ1)-His at 4°C for 4 h, treated with ARHI-His or 
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NTD-His at 4°C for 4h, the samples were separated with SDS-PAGE, then blotted with 
monoclonal antibodies to His or polyclonal antibody to importin 13. 
 
 






